SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905148-16-001815
Filing Date
2016-08-09
Accepted
2016-08-09 17:24:37
Documents
1
Period of Report
2016-06-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 4111
  Complete submission text file 0000905148-16-001815.txt   5427
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 CRESCENT COURT SUITE 250 DALLAS TX 75201
Business Address
McGaughy R Kent Jr (Reporting) CIK: 0001402856 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37785 | Film No.: 161819289